PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 86 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 1.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $1,372,000 | -57.9% | 340,323 | -54.9% | 3.14% | -59.2% |
| Q3 2019 | $3,257,000 | +20.3% | 753,882 | +11.1% | 7.69% | +20.0% |
| Q2 2019 | $2,708,000 | -23.2% | 678,795 | +3.2% | 6.41% | -25.2% |
| Q1 2019 | $3,525,000 | +52.5% | 657,696 | +46.0% | 8.58% | +79.6% |
| Q4 2018 | $2,311,000 | -5.4% | 450,406 | +78.9% | 4.78% | +6.6% |
| Q3 2018 | $2,442,000 | -7.0% | 251,766 | -2.2% | 4.48% | -23.4% |
| Q2 2018 | $2,627,000 | +2.4% | 257,530 | +30.5% | 5.85% | +3.5% |
| Q1 2018 | $2,566,000 | +42.4% | 197,347 | +96.0% | 5.65% | +46.3% |
| Q4 2017 | $1,802,000 | -29.2% | 100,679 | -0.7% | 3.86% | -35.5% |
| Q3 2017 | $2,545,000 | -59.0% | 101,399 | -60.7% | 5.99% | -56.3% |
| Q2 2017 | $6,214,000 | +32.3% | 257,748 | +5.6% | 13.71% | +6.8% |
| Q1 2017 | $4,697,000 | -2.4% | 243,983 | -21.9% | 12.84% | +7.4% |
| Q4 2016 | $4,812,000 | +29.9% | 312,475 | +9.7% | 11.96% | +5.6% |
| Q3 2016 | $3,705,000 | -8.2% | 284,811 | -1.8% | 11.32% | +23.5% |
| Q2 2016 | $4,036,000 | +22.5% | 290,136 | +33.6% | 9.16% | +9.7% |
| Q1 2016 | $3,294,000 | -13.0% | 217,128 | +8.8% | 8.36% | -4.7% |
| Q4 2015 | $3,786,000 | -1.3% | 199,555 | -1.1% | 8.77% | +12.7% |
| Q3 2015 | $3,835,000 | -28.4% | 201,845 | -2.8% | 7.78% | -17.5% |
| Q2 2015 | $5,353,000 | -19.4% | 207,703 | -2.2% | 9.43% | -11.7% |
| Q1 2015 | $6,641,000 | -25.6% | 212,438 | -8.2% | 10.68% | -5.3% |
| Q4 2014 | $8,923,000 | – | 231,478 | – | 11.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 2,600,410 | $33,805,000 | 33.22% |
| Abingworth LLP | 1,041,131 | $13,535,000 | 8.41% |
| Roumell Asset Management, LLC | 197,347 | $2,566,000 | 5.65% |
| Trellus Management Company, LLC | 89,700 | $1,166,000 | 2.12% |
| Prosight Management, LP | 148,682 | $1,933,000 | 1.21% |
| Broadfin Capital, LLC | 477,607 | $6,209,000 | 0.97% |
| HIGHLAND CAPITAL MANAGEMENT LP | 959,278 | $12,471,000 | 0.64% |
| ARMISTICE CAPITAL, LLC | 580,000 | $7,540,000 | 0.58% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 103,500 | $1,346,000 | 0.52% |
| Opus Point Partners Management, LLC | 20,000 | $260,000 | 0.51% |